2024 MOGA Annual Scientific Meeting

14-16 August 2024 | International Convention Centre (ICC) Sydney, NSW

About the Meeting

In 2024 oncologists from around Australia are looking forward to gathering in Sydney for our prestigious 45th Annual Scientific Meeting. This year’s theme, Caring for Tomorrow: Bridges in Cancer Care Technology and Innovation promises an enriching educational agenda that will delve into the latest breakthroughs in cancer treatment and research, whilst offering attendees a platform for networking and collaboration. International and local speakers will draw from their innovative work in areas including AI, solid and liquid precision medicine, radiomics and novel drug development to inspire and educate attendees.  

The meeting will also encompass a range of activities including engaging Scientific Sessions, Abstract Presentations, Mentorship Program, Interactive Workshops, Trainee and YOGA Programs and Social Events around the Darling Harbour precinct. The meeting will incorporate a large Industry Exhibition with over 30 stands, Networking Lounge and extensive Poster Display. 

We look forward to welcoming you to Sydney for Australia’s premier Medical Oncology meeting. 

Discounted registration available for MOGA members

KEYNOTE speakers

Dr Bob T. Li

Dr Bob T. Li, MD, PhD, MPH, FRACP, is an Australian medical oncologist and physician-scientist at Memorial Sloan Kettering Cancer Center, New York, and tenure-track associate professor at Weill Cornell Medicine, Cornell University, who specializes in novel drug development for lung cancers and solid tumors. He is Chief Scientific Officer, MSK Direct, responsible for scientific innovation in MSK’s digital outreach strategy and is also Co-Director of MSK’s multidisciplinary Thoracic Liquid Biopsy Program.

Dr. Li is international principal investigator of multiple pivotal clinical trials of precision medicines which have resulted in historic FDA approvals of targeted therapies for patients with lung cancers. Dr. Li has received numerous awards for his practice changing research and has published over a hundred original articles in scientific journals. He has helped launch the multi-stakeholder Bloomberg New Economy International Cancer Coalition, and his work on patient-centric international clinical trials as part of a growing global movement is frequently featured on Forbes.com.

Professor Vivian Strong

Vivian E. Strong, MD, FACS, is a Vice Chair in the Department of Surgery and holds the Iris Cantor Endowed Chair at Memorial Sloan-Kettering Cancer Center (MSKCC). She is also Professor of Surgery and Associate Dean at Weill Medical College of Cornell University. She specializes in the management of patients with Gastric Cancer and Adrenal Tumors at MSKCC and has authored over 150 publications and over 25 book chapters and reviewed and edited textbooks on gastric cancer and robotic surgery. She received her MD degree with honors from Weill Medical College of Cornell University and completed her residency training at New York Hospital – Cornell. She then completed an advanced laparoscopic fellowship at Cornell and Columbia University before joining the staff at MSKCC in 2005. She has performed over 1,000 gastrectomies and over 500 robotic gastrectomies, establishing one of the most extensive experiences in the U.S.

From a research perspective, she focuses on clinical, molecular and translational research in gastric cancer, adrenal tumors and application of minimally invasive approaches. Currently, she has multiple IRB-approved clinical protocols ongoing at MSKCC. She has also been awarded multiple teaching awards, including the Alpha Omega Alpha Honor Medical Society Teaching Award.

Dr Alexander T. Pearson

Alexander T. Pearson MD, PhD is Director of Data Sciences and Director of Head/Neck Cancer for Hematology/Oncology at the University of Chicago. Dr. Pearson trained as a PhD statistician and physician at the University of Rochester, and then completed both subspecialty training in Hematology/Oncology and postdoctoral research in mathematical systems biology at the University of Michigan. Dr. Pearson’s research lab runs projects using machine learning, mathematical modeling, artificial intelligence (AI), quantum computing, and systems biology. Dr. Pearson’s research group described how deep learning methods could infer molecular cancer states directly from tumor digital pathology images, and has produced methods to decrease algorithm bias and increase physician trustworthiness in AI.

Dr. Pearson is a member of multiple international research consortia for AI and mathematical oncology, and his research work is funded by US Departments of Health, Defense, and Energy, as well as the EU and multiple foundations. He serves on the NIH National Advisory Dental and Craniofacial Research Council (NADCRC) for NIDCR data science strategy, the American Society of Clinical Oncology (ASCO) AI in Oncology Task Force, and the American Medical Association AI Specialty Society Collaborative. As a clinician, Dr. Pearson is an expert in head and neck cancer treatment, and he runs multiple clinical trials to improve cancer treatment in this field. He also serves on organizing committees for the ASCO Annual Meeting, the ASCO Breakthrough Meeting, and the Multidisciplinary Head and Neck Cancers Symposia.

2024 ASM sponsors

Gold Sponsor

Exhibitors